U.S. flag An official website of the United States government
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
  1. Recalls, Market Withdrawals, & Safety Alerts


Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos


Company Announcement Date:
FDA Publish Date:
Product Type:
Reason for Announcement:
Recall Reason Description
Insanitary manufacturing conditions
Company Name:
Cardinal Health, Inc.
Brand Name:
Brand Name(s)
Product Description:
Product Description
OTC Ophthalmic Sterile Drops

Company Announcement

FOR IMMEDIATE RELEASE – October 31, 2023 – Dublin, OH, Cardinal Health, Inc. is initiating a voluntarily recall for all lots of ophthalmic products supplied by Velocity Pharma, LLC to the consumer level. Cardinal Health, Inc. received information from FDA indicating investigators found insanitary conditions in the manufacturing facility and positive bacterial test results from environmental sampling of critical drug production areas in the facility.

Risk Statement: For those patients who use these products, there is a potential risk of eye infections that could result in partial vision loss or blindness. These products are intended to be sterile. Ophthalmic drug products pose a potential heightened risk of harm to users because drug applied to the eyes bypass some of the body’s natural defenses. To date, Cardinal Health, Inc., and its subsidiaries have received reports of three (3) adverse events related to these listed products. The reports of adverse events were shared with our supplier, Velocity Pharma, LLC.

These products are available as over the counter (OTC) products used for temporary relief of burning and irritation due to dryness of the eye, for use as a protectant against further irritation or to relieve dryness of the eye, and/or to relieve redness of the eye due to minor eye irritations.

These products can be identified on the outer carton labeling as follows:

Product Name Package
Eye Irritation Relief (Polyvinyl Alcohol,
0.5%, Povidone, 0.6%, and
Tetrahydrozoline Hydrochloride, 0.05%)
0.5 FL OZ bottle
(15 mL)
LEADER™ 70000-0087-1
Dry Eye Relief
(Carboxymethylcellulose Sodium, 1%)
0.5 FL OZ bottle
(15 mL)
LEADER™ 70000-0089-1
Lubricant Eye Drops
(Carboxymethylcellulose Sodium, 0.5%)
0.5 FL OZ bottle
(15 mL)
LEADER™ 70000-0090-1
Lubricant Eye Drops
(Carboxymethylcellulose Sodium, 0.5%)
2 bottles, 0.5 FL
OZ (15 mL) each
LEADER™ 70000-0090-2
Dry Eye Relief (Polyethylene Glycol 400,
0.4% and Propylene Glycol, 0.3%)
0.33 FL OZ bottle
(10 mL)
LEADER™ 70000-0088-1
Lubricant Eye Drops
(Propylene Glycol, 0.6%)
0.33 FL OZ bottle
(10 mL)
LEADER™ 70000-0587-1

Images of the outer carton labeling of these listed products can be found below.

Products were distributed Nationwide to Wholesalers and Retailers starting December 12, 2021.

Cardinal Health, Inc. is notifying all impacted direct accounts via mail of this voluntary recall and is arranging for return of all recalled products listed above. Wholesalers, Distributors and Retailers that have the affected product which is being recalled should cease distribution of the products. Consumers should stop using the recalled eye drop products and may return any of the above listed products to the place of purchase.

Consumers with questions regarding this recall can contact Sedgwick, Inc. by phone at 1-855-215-4940 (8:00am-5:00pm EST Monday through Friday) or by email at Cardinalhealth7720@sedgwick.com. Consumers who have signs or symptoms of an eye infection after using these products should talk to their health care provider or seek medical care immediately.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


Company Contact Information

Sedgwick, Inc.
Erich Timmerman

Product Photos

Back to Top